168 related articles for article (PubMed ID: 34581019)
41. Kuanoniamine C stimulates bortezomib-induced cell death via suppression of glucose-regulated protein 78 in osteosarcoma.
Machihara K; Namba T
Biochem Biophys Res Commun; 2020 Jun; 527(1):289-296. PubMed ID: 32446382
[TBL] [Abstract][Full Text] [Related]
42. Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.
Ando T; Ichikawa J; Okamoto A; Tasaka K; Nakao A; Hamada Y
J Orthop Res; 2005 Jul; 23(4):964-9. PubMed ID: 16023013
[TBL] [Abstract][Full Text] [Related]
43. Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan.
Ma L; Chen Y; Wang X; Xiong M; Sun Y; Zhang X; Zhao Y
Bioorg Med Chem Lett; 2018 Sep; 28(17):2920-2924. PubMed ID: 30017318
[TBL] [Abstract][Full Text] [Related]
44. Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
Geromichalou E; Sayyad N; Kyriakou E; Chatzikonstantinou AV; Giannopoulou E; Vrbjar N; Kalofonos HP; Stamatis H; Tzakos AG
Eur J Med Chem; 2015; 96():47-57. PubMed ID: 25874330
[TBL] [Abstract][Full Text] [Related]
45. Effectiveness of two novel anionic and cationic platinum complexes in the treatment of osteosarcoma.
Igarashi K; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Odani A; Tsuchiya H
Anticancer Agents Med Chem; 2015; 15(3):390-9. PubMed ID: 25511510
[TBL] [Abstract][Full Text] [Related]
46. Liposomal squalenoyl-gemcitabine: formulation, characterization and anticancer activity evaluation.
Pili B; Reddy LH; Bourgaux C; Lepêtre-Mouelhi S; Desmaële D; Couvreur P
Nanoscale; 2010 Aug; 2(8):1521-6. PubMed ID: 20820745
[TBL] [Abstract][Full Text] [Related]
47. Squalenoylation: a generic platform for nanoparticular drug delivery.
Desmaële D; Gref R; Couvreur P
J Control Release; 2012 Jul; 161(2):609-18. PubMed ID: 21840355
[TBL] [Abstract][Full Text] [Related]
48. 15,16-dihydrotanshinone I Induces Apoptosis and Inhibits the Proliferation, Migration of Human Osteosarcoma Cell Line 143B in vitro.
Chen X; Li Q; He Y; Du H; Zhan Z; Zhao H; Shi J; Ye Q; Hu J
Anticancer Agents Med Chem; 2017; 17(9):1234-1242. PubMed ID: 26478521
[TBL] [Abstract][Full Text] [Related]
49. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
Zhang C; Ma K; Li WY
Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
[TBL] [Abstract][Full Text] [Related]
50. Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
Bekkara-Aounallah F; Ambike A; Gref R; Couvreur P; Rosilio V
Int J Pharm; 2014 Aug; 471(1-2):75-82. PubMed ID: 24811925
[TBL] [Abstract][Full Text] [Related]
51. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line.
Tao H; Chen F; Liu H; Hu Y; Wang Y; Li H
Mol Med Rep; 2017 Aug; 16(2):1701-1706. PubMed ID: 28656199
[TBL] [Abstract][Full Text] [Related]
52. Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.
Kreahling JM; Foroutan P; Reed D; Martinez G; Razabdouski T; Bui MM; Raghavan M; Letson D; Gillies RJ; Altiok S
PLoS One; 2013; 8(3):e57523. PubMed ID: 23520471
[TBL] [Abstract][Full Text] [Related]
53. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: the role of Akt and nuclear factor-kappaB.
Zhang B; Shi ZL; Liu B; Yan XB; Feng J; Tao HM
Anticancer Drugs; 2010 Mar; 21(3):288-96. PubMed ID: 20038829
[TBL] [Abstract][Full Text] [Related]
54. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
McMahon MB; Bear MD; Kulp SK; Pennell ML; London CA
Am J Vet Res; 2010 Jul; 71(7):799-808. PubMed ID: 20594083
[TBL] [Abstract][Full Text] [Related]
55. A multiple drug loaded, functionalized pH-sensitive nanocarrier as therapeutic and epigenetic modulator for osteosarcoma.
Yuan Y; Song JX; Zhang MN; Yuan BS
Sci Rep; 2020 Sep; 10(1):15497. PubMed ID: 32968136
[TBL] [Abstract][Full Text] [Related]
56. Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.
Reddy LH; Ferreira H; Dubernet C; Mouelhi SL; Desmaele D; Rousseau B; Couvreur P
Anticancer Drugs; 2008 Nov; 19(10):999-1006. PubMed ID: 18827565
[TBL] [Abstract][Full Text] [Related]
57. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue.
Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR
Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248
[TBL] [Abstract][Full Text] [Related]
58. The role of solvent swelling in the self-assembly of squalene based nanomedicines.
Saha D; Testard F; Grillo I; Zouhiri F; Desmaele D; Radulescu A; Desert S; Brulet A; Couvreur P; Spalla O
Soft Matter; 2015 Jun; 11(21):4173-9. PubMed ID: 25873336
[TBL] [Abstract][Full Text] [Related]
59. Cationic Supramolecular Vesicular Aggregates for Pulmonary Tissue Selective Delivery in Anticancer Therapy.
Licciardi M; Paolino D; Mauro N; Cosco D; Giammona G; Fresta M; Cavallaro G; Celia C
ChemMedChem; 2016 Aug; 11(16):1734-44. PubMed ID: 27273893
[TBL] [Abstract][Full Text] [Related]
60. Gemcitabine Lipid Prodrugs: The Key Role of the Lipid Moiety on the Self-Assembly into Nanoparticles.
Coppens E; Desmaële D; Mougin J; Tusseau-Nenez S; Couvreur P; Mura S
Bioconjug Chem; 2021 Apr; 32(4):782-793. PubMed ID: 33797231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]